NO20042822L - Forlenget frigjoring - farmasoytisk tablett av metformin - Google Patents
Forlenget frigjoring - farmasoytisk tablett av metforminInfo
- Publication number
- NO20042822L NO20042822L NO20042822A NO20042822A NO20042822L NO 20042822 L NO20042822 L NO 20042822L NO 20042822 A NO20042822 A NO 20042822A NO 20042822 A NO20042822 A NO 20042822A NO 20042822 L NO20042822 L NO 20042822L
- Authority
- NO
- Norway
- Prior art keywords
- metformin
- extended release
- released
- hours
- pharmaceutical tablet
- Prior art date
Links
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title abstract 7
- 229960003105 metformin Drugs 0.000 title abstract 7
- 238000013265 extended release Methods 0.000 title abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/005,387 US20030118647A1 (en) | 2001-12-04 | 2001-12-04 | Extended release tablet of metformin |
PCT/US2002/038599 WO2003047529A2 (en) | 2001-12-04 | 2002-12-04 | Extended release pharmaceutical tablet of metformin |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20042822L true NO20042822L (no) | 2004-08-26 |
NO333929B1 NO333929B1 (no) | 2013-10-21 |
Family
ID=21715581
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20042822A NO333929B1 (no) | 2001-12-04 | 2004-07-02 | Forlenget frigjøring - farmasøytisk tablett av metformin |
NO20130984A NO20130984L (no) | 2001-12-04 | 2013-07-16 | Forlenget frigjøring - farmasøytisk tablett av metformin |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20130984A NO20130984L (no) | 2001-12-04 | 2013-07-16 | Forlenget frigjøring - farmasøytisk tablett av metformin |
Country Status (12)
Country | Link |
---|---|
US (3) | US20030118647A1 (no) |
EP (1) | EP1460998B1 (no) |
AT (1) | ATE460157T1 (no) |
AU (1) | AU2002359582C1 (no) |
CA (1) | CA2470747C (no) |
DE (1) | DE60235648D1 (no) |
ES (1) | ES2338536T3 (no) |
HU (1) | HU229962B1 (no) |
MX (1) | MXPA04005667A (no) |
NO (2) | NO333929B1 (no) |
NZ (1) | NZ533857A (no) |
WO (1) | WO2003047529A2 (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1322158B1 (en) * | 2000-10-02 | 2012-08-08 | USV Ltd. | Sustained release pharmaceutical compositions containing metformin and method of their production |
KR200249057Y1 (ko) * | 2001-03-22 | 2001-10-19 | 김진환 | 뚜껑, 받침대에 합체된 하수역류. 악취방지 장치 |
US8323692B2 (en) | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
SI1476138T1 (sl) * | 2002-02-21 | 2012-07-31 | Valeant Internat Barbados Srl | Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola |
WO2003105809A1 (en) | 2002-06-17 | 2003-12-24 | Themis Laboratories Private Limited | Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them |
US9060941B2 (en) * | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US8084058B2 (en) | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US7959946B2 (en) * | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US7785627B2 (en) | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
WO2005123134A2 (en) * | 2004-05-14 | 2005-12-29 | Cadila Healthcare Limited | A controlled release delivery system for metformin |
US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
EP2623099A1 (en) | 2004-11-24 | 2013-08-07 | Neuromolecular Pharmaceuticals, Inc | Composition and method for treating neurological disease |
KR100780553B1 (ko) * | 2005-08-18 | 2007-11-29 | 한올제약주식회사 | 메트포르민 서방정 및 그의 제조방법 |
KR100858848B1 (ko) * | 2006-05-23 | 2008-09-17 | 한올제약주식회사 | 메트포르민 서방정 |
EP2219633A2 (en) * | 2007-11-23 | 2010-08-25 | Nectid, Inc. | Tapentadol compositions |
WO2010026467A2 (en) * | 2008-09-04 | 2010-03-11 | Torrent Pharmaceuticals Ltd. | Controlled release dosage form of high solubility active ingredient |
BR112012013487A2 (pt) | 2009-12-02 | 2017-10-03 | Adamas Pharmaceuticals Inc | Composições de amantadina e métodos de uso |
EA029077B1 (ru) * | 2010-03-09 | 2018-02-28 | Алкермес Фарма Айэленд Лимитед | Устойчивая к спирту фармацевтическая лекарственная форма |
US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
CN103622930B (zh) * | 2013-12-19 | 2015-06-10 | 石家庄市华新药业有限责任公司 | 一种盐酸二甲双胍缓释制剂及其制备方法 |
WO2016042567A1 (en) * | 2014-09-16 | 2016-03-24 | Suresh Pareek | Extended release formulation of metformin |
CA3096239C (en) * | 2018-03-29 | 2023-03-28 | Tata Chemicals Limited | Encapsulated micronutrient granules for fortification of edible salt compositions |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2001A (en) * | 1841-03-12 | Sawmill | ||
US4721709A (en) * | 1984-07-26 | 1988-01-26 | Pyare Seth | Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions |
US4892742A (en) * | 1985-11-18 | 1990-01-09 | Hoffmann-La Roche Inc. | Controlled release compositions with zero order release |
CH672888A5 (no) * | 1986-11-07 | 1990-01-15 | Mepha Ag | |
CH668553A5 (de) * | 1987-02-02 | 1989-01-13 | Mepha Ag | Arzneimittel mit verzoegerter wirkstofffreisetzung. |
US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
US5472712A (en) * | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5451409A (en) * | 1993-11-22 | 1995-09-19 | Rencher; William F. | Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends |
FR2723536A1 (fr) * | 1994-08-11 | 1996-02-16 | Seth Pawan | Composition permettant une liberation selective d'un principe actif |
DE4432757A1 (de) * | 1994-09-14 | 1996-03-21 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung |
US6348469B1 (en) * | 1995-04-14 | 2002-02-19 | Pharma Pass Llc | Solid compositions containing glipizide and polyethylene oxide |
US6117453A (en) * | 1995-04-14 | 2000-09-12 | Pharma Pass | Solid compositions containing polyethylene oxide and an active ingredient |
PL186605B1 (pl) * | 1995-09-21 | 2004-01-30 | Pharma Pass Llc | Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol |
US6048547A (en) * | 1996-04-15 | 2000-04-11 | Seth; Pawan | Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
US6099859A (en) * | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
US6099862A (en) * | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
US6096341A (en) * | 1998-10-30 | 2000-08-01 | Pharma Pass Llc | Delayed release tablet of bupropion hydrochloride |
US6033686A (en) * | 1998-10-30 | 2000-03-07 | Pharma Pass Llc | Controlled release tablet of bupropion hydrochloride |
DE19915420A1 (de) * | 1999-04-06 | 2000-10-12 | Basf Ag | Stabilisierte Polyvinylpyrrolidon-Zubereitungen |
US6368628B1 (en) * | 2000-05-26 | 2002-04-09 | Pharma Pass Llc | Sustained release pharmaceutical composition free of food effect |
US6338857B1 (en) * | 2000-05-26 | 2002-01-15 | Pharma Pass Llc | Sustained release carbamazepine pharmaceutical composition free of food effect and a method for alleviating food effect in drug release |
US6350471B1 (en) * | 2000-05-31 | 2002-02-26 | Pharma Pass Llc | Tablet comprising a delayed release coating |
US20030021841A1 (en) * | 2001-07-02 | 2003-01-30 | Matharu Amol Singh | Pharmaceutical composition |
-
2001
- 2001-12-04 US US10/005,387 patent/US20030118647A1/en not_active Abandoned
-
2002
- 2002-12-04 ES ES02794129T patent/ES2338536T3/es not_active Expired - Lifetime
- 2002-12-04 EP EP02794129A patent/EP1460998B1/en not_active Expired - Lifetime
- 2002-12-04 US US10/309,193 patent/US20030170302A1/en not_active Abandoned
- 2002-12-04 AU AU2002359582A patent/AU2002359582C1/en not_active Ceased
- 2002-12-04 NZ NZ533857A patent/NZ533857A/en not_active IP Right Cessation
- 2002-12-04 HU HU0500004A patent/HU229962B1/hu not_active IP Right Cessation
- 2002-12-04 WO PCT/US2002/038599 patent/WO2003047529A2/en not_active Application Discontinuation
- 2002-12-04 DE DE60235648T patent/DE60235648D1/de not_active Expired - Lifetime
- 2002-12-04 AT AT02794129T patent/ATE460157T1/de not_active IP Right Cessation
- 2002-12-04 CA CA002470747A patent/CA2470747C/en not_active Expired - Fee Related
- 2002-12-04 MX MXPA04005667A patent/MXPA04005667A/es active IP Right Grant
-
2004
- 2004-02-04 US US10/771,987 patent/US20040161461A1/en not_active Abandoned
- 2004-07-02 NO NO20042822A patent/NO333929B1/no not_active IP Right Cessation
-
2013
- 2013-07-16 NO NO20130984A patent/NO20130984L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA04005667A (es) | 2005-06-17 |
ATE460157T1 (de) | 2010-03-15 |
CA2470747C (en) | 2009-07-28 |
ES2338536T3 (es) | 2010-05-10 |
WO2003047529A2 (en) | 2003-06-12 |
HU229962B1 (hu) | 2015-03-30 |
AU2002359582B2 (en) | 2007-01-18 |
AU2002359582C1 (en) | 2008-11-13 |
US20040161461A1 (en) | 2004-08-19 |
DE60235648D1 (de) | 2010-04-22 |
US20030118647A1 (en) | 2003-06-26 |
CA2470747A1 (en) | 2003-06-12 |
HUP0500004A2 (hu) | 2005-04-28 |
NO333929B1 (no) | 2013-10-21 |
AU2002359582A1 (en) | 2003-06-17 |
WO2003047529A3 (en) | 2003-10-30 |
NO20130984L (no) | 2004-08-26 |
EP1460998A4 (en) | 2005-09-14 |
HUP0500004A3 (en) | 2012-09-28 |
EP1460998B1 (en) | 2010-03-10 |
EP1460998A2 (en) | 2004-09-29 |
NZ533857A (en) | 2007-05-31 |
US20030170302A1 (en) | 2003-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20042822L (no) | Forlenget frigjoring - farmasoytisk tablett av metformin | |
BR9908438A (pt) | Tabletes de desintegração rápida | |
ATE211907T1 (de) | Osmotisches arzneimittelfreisetzungssystem | |
SE9704869D0 (sv) | New pharmaceutical formulaton II | |
WO2003072025A3 (en) | Modified release formulations of at least one form of tramadol | |
DOP2013000023A (es) | Un compuesto seleccionado del acido 6-(4-bromo-2-cloro-fenilamino) -7-fluror-3-metil-3h-benzoimidazol -5-carboxilico (2-hidroxi-etoxi)-amida y sales farmaceuticamente aceptables del mismo, y composiciones farmaceuticas que contienen dicho compuesto | |
PE20030527A1 (es) | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen | |
DK1239857T3 (da) | Dual-release-præparater af en cyclooxygenase-2-hæmmer | |
NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
DK1293196T3 (da) | Farmaceutisk præparat der omfatter doxazosin | |
DK1113787T3 (da) | Agitationsuafhængige farmaceutiske multipelenhedsretardformuleringer og fremgangsmåde til deres fremstilling | |
FI914354A0 (fi) | Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi | |
AR036658A1 (es) | Formulacion de dosificacion oral de fundicion instantanea | |
IS2691B (is) | Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð | |
AR014012A1 (es) | Formula de liberacion prolongada | |
GB0012362D0 (en) | Chemical compounds | |
GR1003658B (el) | Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου | |
WO2003005967A3 (en) | Dual release levodopa ethyl ester and decarboxylase in controlled release core | |
MXPA04003346A (es) | Formulacion de dosis oral de disolucion instantanea. | |
PT1425005E (pt) | Composicao farmaceutica que compreende lumiracoxib | |
FI932552A0 (fi) | Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen | |
MXPA04007437A (es) | Sistema de suministro osmotico. | |
NO996049D0 (no) | Kontrollert-frigjøring farmasoeytisk preparat med ACE inhibitor som aktivt middel | |
DK0966283T3 (da) | Farmaceutiske præparater til helbredelse og forebyggelse af sygdomme, som stammer fra beskadigelse af vaskulære endotelceller |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: VALEANT INTERNATIONAL BERMUD, BM |
|
MM1K | Lapsed by not paying the annual fees |